STEVENSON, Md.--(BUSINESS WIRE)--The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Bio-Reference Laboratories, Inc. (“Bio-Reference” or the “Company”) (NasdaqGS: BRLI) relating to the proposed buyout of the Company by OPKO Health, Inc. Under the terms of the transaction, Bio-Reference shareholders are anticipated to receive 2.75 sha
| < Prev | Next > |
|---|
